Fujisawa Report issue

Contributed to NME For profit Phase 3
Founded: Osaka Japan (1894)
Status: Acquired by Astellas (2005) → now Leo Pharma (2015)

Organization Overview

First Clinical Trial
1999
NCT00001028
First Marketed Drug
1991
tacrolimus (prograf)
First NDA Approval
1994
tacrolimus (prograf)
Last Known Activity
2005

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Fujisawa GmbH | FUJISAWA HLTHCARE | Fujisawa Pharmaceutical Co